U.S. markets close in 1 hour 58 minutes

AMAG Pharmaceuticals, Inc. (AMAG)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
13.73+0.02 (+0.11%)
As of 2:02PM EDT. Market open.
Show:
Income Statement
Balance Sheet
Cash Flow
Annual
Premium required to access quarterly data
Quarterly
Subscribe to Premium to download historical data

Income Statement

All numbers in thousands
Get access to 40+ years of historical data with Yahoo Finance Premium.Learn more
Breakdown
ttm
12/31/2019
12/31/2018
12/31/2017
12/31/2016
Total Revenue
297,696
327,751
474,002
609,946
532,091
Cost of Revenue
106,965
107,193
215,892
183,166
116,889
Gross Profit
190,731
220,558
258,110
426,780
415,202
Operating Expense
278,359
351,723
322,263
382,636
290,271
Operating Income
-87,628
-131,165
-64,153
44,144
124,931
Net Non Operating Interest Income Expense
-23,953
-21,424
-46,643
-65,572
-70,004
Other Income Expense
-147,108
-313,914
-18,889
-348,666
-45,872
Pretax Income
-258,689
-466,503
-129,685
-370,094
9,055
Tax Provision
150
-47
39,654
-170,866
11,538
Net Income Common Stockholders
-258,839
-466,456
-65,761
-199,228
-2,483
Diluted NI Available to Com Stockholders
-258,839
-466,456
-65,761
-199,228
-2,483
Basic EPS
-
-0.0137
-0.0019
-0.0057
0
Diluted EPS
-
-0.0137
-0.0019
-0.0057
0
Basic Average Shares
-
34,030
34,394
34,907
34,346
Diluted Average Shares
-
34,030
34,394
34,907
34,346
Total Operating Income as Reported
-236,110
-445,507
-47,046
-293,261
78,870
Total Expenses
385,324
458,916
538,155
565,802
407,160
Net Income from Continuing & Discontinued Operation
-258,839
-466,456
-65,761
-199,228
-2,483
Normalized Income
-150,447
-152,114
-155,604
9,771
25,154
Interest Income
2,279
4,285
5,328
2,810
3,149
Interest Expense
24,820
24,297
51,971
68,382
73,153
Net Interest Income
-23,953
-21,424
-46,643
-65,572
-70,004
EBIT
-233,869
-442,206
-77,714
-301,712
82,208
EBITDA
-195,843
-
-
-
-
Reconciled Cost of Revenue
106,965
107,193
215,892
43,347
29,532
Reconciled Depreciation
38,026
27,324
172,223
155,538
99,886
Net Income from Continuing Operation Net Minority Interest
-258,839
-466,456
-169,339
-199,228
-2,483
Total Unusual Items Excluding Goodwill
-148,482
-314,342
-18,815
-348,331
-46,061
Total Unusual Items
-148,482
-314,342
-18,815
-348,331
-46,061
Normalized EBITDA
-47,361
-100,540
113,324
202,157
228,155
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
-40,090
0
-5,080
-139,332
-18,424